Literature DB >> 20951757

Neuropsychological functions in Han Chinese patients in Taiwan with bipolar II disorder comorbid and not comorbid with alcohol abuse/alcohol dependence disorder.

Cindy Shan1, Sheng-Yu Lee, Yun-Hsuan Chang, Jo Yung-Wei Wu, Shiou-Lan Chen, Shih-Heng Chen, Yih-Lynn Hsiao, Hsin-Fen Yang, I Hui Lee, Po See Chen, Tzung Lieh Yeh, Yen Kuang Yang, Ru-Band Lu.   

Abstract

OBJECTIVE: Studies exploring neuropsychological functions of bipolar disorder (BP) specifically include patients comorbid with alcohol abuse (AB), alcohol dependence (AD), or both (AB/AD). Contradictory assessments of neuropsychological impairment may be caused by not excluding the confounding effects of comorbid AB/AD. Most of the literature discusses BP without subtyping, which overlooks that BP-II may be a valid diagnosis different from BP-I. Because neuropsychological functions are involved in overall BP-II outcomes, we hypothesized that the neuropsychological functions of patients with BP-II comorbid with AD (BP(+AD)) are significantly different from and more impaired than those of patients with BP-II not comorbid with AD (BP(-AD)).
METHODS: Using DSM-IV criteria, the study included 69 patients with BP-II (19 with BP(+AD); 28 with BP(-AD)) and 22 healthy controls compared using a battery of neuropsychological tests that assessed memory, psychomotor speed, and certain aspects of frontal executive function. All BP-II patients were in an inter-episode period (a period of remission between states of mania, hypomania, and depression).
RESULTS: BP(+AD) patients had lower scores than did BP(-AD) patients and controls in verbal memory, visual memory, attention, psychomotor speed, and executive function. Working memory was poorer for BP(+AD) than BP(-AD) patients and for both BP groups than for controls.
CONCLUSIONS: BP(+AD) patients manifested wide neuropsychological dysfunctions, and BP(-AD) patients showed a reduction in working memory, which suggested that working memory might be related to a history of BP-II. Neuropsychological dysfunctions seemed more strongly associated with AB/AD than with BP-II in inter-episode periods.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20951757     DOI: 10.1016/j.pnpbp.2010.10.004

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  5 in total

1.  Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.

Authors:  Sheng-Yu Lee; Tzu-Yun Wang; Shiou-Lan Chen; Yun-Hsuan Chang; Po-See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Liang-Jen Wang; I Hui Lee; Kao Ching Chen; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Alcohol Clin Exp Res       Date:  2018-05-17       Impact factor: 3.455

2.  Neurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

Authors:  Leonardo E Silveira; Jan-Marie Kozicky; Kesavan Muralidharan; Joana Bücker; Ivan J Torres; David J Bond; Flavio Kapczinski; Marcia Kauer-Sant'Anna; Raymond W Lam; Lakshmi N Yatham
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

3.  Neuroprotective and neurogenesis agent for treating bipolar II disorder: add-on memantine to mood stabilizer works.

Authors:  Ru-Band Lu; Shiou-Lan Chen; Sheng-Yu Lee; Yun-Hsuan Chang; Shih-Heng Chen; Chun-Hsieh Chu; Nian-Sheng Tzeng; I Hui Lee; Po See Chen; Tzung Lieh Yeh; San-Yuan Huang; Yen Kuang Yang; Jau-Shyong Hong
Journal:  Med Hypotheses       Date:  2012-06-05       Impact factor: 1.538

4.  Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients.

Authors:  Ting-Ting Jiang; Xiao-Li Liu; Yu-Yong Jiang; Xian-Bo Wang; Zhi-Yun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-07       Impact factor: 2.629

Review 5.  Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates.

Authors:  Vicent Balanzá-Martínez; Benedicto Crespo-Facorro; Ana González-Pinto; Eduard Vieta
Journal:  Front Physiol       Date:  2015-04-07       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.